We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

15 hedge funds and large institutions have $7.31M invested in Allied Healthcare Products in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $7M → $7.31M (+$309K)

0% more funds holding

Funds holding: 1515 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q2 2014 in Review

15 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q2 2014, worth a combined $7.31M — up 4.4% from $7M a quarter earlier.

Fund positioning in AHPI was balanced in Q2 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 5 trimmed.

The largest buyer was Managed Account Advisors, adding an estimated $1.16K. The largest seller was Wells Fargo, cutting an estimated $124K.

  • 15 institutional investors held Allied Healthcare Products (AHPI) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $7.31M of Allied Healthcare Products stock for Q2 2014, up 4.4% quarter-over-quarter.
  • 1 fund opened new Allied Healthcare Products positions in Q2 2014 and 1 closed out, a net change of 0 holders.
  • The largest Allied Healthcare Products buyer in Q2 2014 was Managed Account Advisors, an estimated $1.16K added.
  • The largest Allied Healthcare Products seller in Q2 2014 was Wells Fargo, an estimated $124K sold.

Based on aggregated 13F filings for Q2 2014.